Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-006135-12Phase 4Completed
Phase 4, randomised trial of hetastarch and iopamidol in ovarian cancer (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Total intraoperative intravenous fluid volume. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-006135-12.